Search International and National Patent Collections

1. (WO2017036880) NR2B SELECTIVE NMDA-RECEPTOR ANTAGONISTS FOR TREATMENT OF IMMUNE-MEDIATED INFLAMMATORY DISEASES

Pub. No.:    WO/2017/036880    International Application No.:    PCT/EP2016/069975
Publication Date: Fri Mar 10 00:59:59 CET 2017 International Filing Date: Thu Aug 25 01:59:59 CEST 2016
IPC: A61K 31/55
A61P 37/06
Applicants: WESTFÄLISCHE WILHELMS-UNIVERSITÄT MÜNSTER
Inventors: BITTNER, Stefan
MEUTH, Sven
WÜNSCH, Bernhard
SCHEPMANN, Dirk
Title: NR2B SELECTIVE NMDA-RECEPTOR ANTAGONISTS FOR TREATMENT OF IMMUNE-MEDIATED INFLAMMATORY DISEASES
Abstract:
The present invention provides novel means and methods for treatment auf immunemediated inflammatory diseases.